“showed a trend”

At day 0.5, the expression of Opn1sw showed a trend to decrease after MNU-S treatment ( p = 0.10) while no difference from control was observed after MNU-T and MMS treatment (Fig. 3 A).

In terms of the LAT1 mRNA abundance, the 0.02% group was noticeably richer than the control group, and the 0.04% group showed a trend to intensify its expression (0.05 < P < 0.10).

It also significantly increased the relative mRNA expression level of Nrf2 in the ileal tissue of 1-day-old chicks ( P < 0.05) and showed a trend of reducing the relative expression level of IL-10 ( P < 0.10).

EB677063 ) showed a trend towards up regulation in SBM fed fish compared to FM fed fish ( P < 0.10) ( Table 4 and Fig. 2 Ab).

Similarly, the PCoA plot based on unweighted UniFrac distances showed a trend toward segregation between PRE and POST samples ( p = 0.1, PERMANOVA), while the weighted UniFrac-based PCoA plot did not ( Supplementary Materials, Figure S2 ).

OS for local IHC equivocal (IHC 2+) was similar to that of local IHC positive (Figure 2 A: HR = 1.0; 95% CI, 0.43 to 2.6; P = 0.92) and showed a trend of shorter OS compared with local IHC negative (HR = 2.7; 95% CI, 0.82 to 9.2; P = 0.10).

36 (30 – 47), p = 0.70), and still showed a trend toward lower RVSP with respect to the pre-surgical echo (47 (37 – 60); p = 0.10).

Patients with MMR-deficient tumors showed a trend towards a better 3-year overall survival (96.3% vs . 83.5%; p = 0.1, log rank).

Furthermore, GCT supplementation to broiler diet showed a trend ( p < 0.10) toward reduced liver TG ( Figure 5B ) level compared with CON broilers.

In this study we were able to show that two haplotypes (GAGTAG in haploblock 2 and CAACCGGG in haploblock 3) were associated with reduced CRYBB2 mRNA expression in lymphocytes, while one haplotype (TAC in haploblock 4) showed a trend ( p < 0.1), which is why these three haplotype blocks were selected for further analysis.

KRAS wild-type individuals with non-overexpressed MKP-1 showed a trend towards longer OS, which was not statistically significant ( P =0.1).

Independent variables were those that showed a trend toward being significant in univariate analyses ( p < .1).

Eight of 13 schizophrenia candidate genes were validated by qPCR (Table 3 ) for an overall validation rate by qPCR of 62% (p < 0.05, two tailed t-test) while the remaining 5 genes showed a trend for validation by qPCR (p < 0.1, two tailed t-test).

The difference between means was considered statistically significant when the p-value was lower than 0.05 (p<0.05), and showed a trend toward a difference in treatment means when the p-value is between 0.05 and 0.10 (0.05<p<0.10).

However, 89 % of Hispanic-Other children aged 9–12 years had an earlier diagnosis compared to 50 % of NHW children, and Hispanic-Other children aged ≥13 years showed a trend (albeit non-significant) toward younger diagnosis age than NHW children ( P = 0.10).

Additionally, we performed exploratory analyses for the left and right hemispheres when a group comparison or correlation between a specific subregion and cognitive domain showed a trend ( p ≤ 0.1) towards significance.

Besides, AFB 1 exposure showed a trend to elevate ( P < 0.10) serum DAO activity, while POS addition tended to lower ( P < 0.10) it regardless of AFB 1 exposure.

The correlation of the overall T cell response with expansion showed a trend that did not reach significance (r = 0.31, p = 0.10; Fig 2H ), while it inversely correlated with contraction (r = -0.53, p = 0.003; Fig 2I ).

Subsequently, a multivariate logistic regression model was stepwise fitted to test variables associated with fatigue that showed a trend with a p -value of <0.1 after univariate analysis.

2.0 ± 0.8 pg/ml, P = 0.062) but showed a trend with P < 0.1.

The analysis of the total time to SR showed a trend towards shorter critical isthmus strategies (1 ± 1 min) compared to individual line (22 ± 49 min) and standard line approaches (57 ± 100 min) ( p = 0.10). 3.4.3.

Regarding the dose difference among the male patients, the benzoate 1000 group, but not the other two benzoate groups, showed a trend (insignificant) improvement in the ADAS‐cog performance than the placebo group at week 24 ( P = 0.10) and endpoint ( P = 0.11) (not shown).

Whilst aacC4 LMM showed a trend towards treatment effect (F(4, 41) = 2.1, P = 0.1), it was clear that the most noticeable change was towards an increased abundance in 80 ppm (3.5 ± 4), which was significantly greater than RLC (1.4 ± 0.9), 0 ppm (0.9 ± 0.7) and 30 ppm (1.3 ± 1.5; P < 0.05 for all), although with rather similar levels to CLC (2.3 ± 2, P = 0.31).

Notably, the AD group demonstrated significantly greater improvement in runny nose at the 6‐month follow‐up ( p < 0.05) and showed a trend towards better improvement in nasal congestion and overall visual analogue scale (VAS) scores compared with the MD group ( p < 0.1).

Respondents with college education showed a trend toward greater ability to name stroke as a salt-related health issue (O.R. 1.51, 95% C.I. 0.96, 2.38, p < 0.10), and those who lived alone were less likely to do so (O.R. 0.68, 95% C.I. 0.42, 1.09), p < 0.10).